(Q36260172)

13 August 2017

Treatment of migraine and tension-type headache in Croatia (English)

1 reference

13 August 2017

0 references

0 references

1 reference

Vlasta Vuković

1

1 reference

13 August 2017

Davor Plavec

2

1 reference

13 August 2017

Arijana Lovrencić Huzjan

3

1 reference

13 August 2017

Mislav Budisić

4

1 reference

13 August 2017

Vida Demarin

5

1 reference

13 August 2017

6 March 2010

1 reference

The journal of headache and pain : official journal of the Italian Society for the Study of Headaches

13 August 2017

1 reference

13 August 2017

11

1 reference

13 August 2017

3

1 reference

13 August 2017

227-234

1 reference

Per-capita consumption of analgesics: a nine-country survey over 20 years

13 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3451912

Triptans in the Italian population: a drug utilization study and a literature review

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3451912

Management of migraine in Australian general practice.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3451912

Prevalence of migraine in Latin America.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3451912

Use and misuse of triptans in France: data from the GRIM2000 population survey

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3451912

The International Classification of Headache Disorders: 2nd edition

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3451912

Migraine prevalence and treatment patterns: the global Migraine and Zolmitriptan Evaluation survey

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3451912

Triptans (serotonin, 5-HT1B/1D agonists) in migraine: detailed results and methods of a meta-analysis of 53 trials

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3451912

Survey on the use of complementary and alternative medicine among patients with headache syndromes

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3451912

One-year prevalence of migraine in Sweden: a population-based study in adults

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3451912

Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3451912

Impact of headache on sickness absence and utilisation of medical services: a Danish population study

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3451912

The diagnosis of headache in primary care: factors in the agreement of clinical and standardized diagnoses.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3451912

Recognition and management of migraine in primary care: influence of functional impact measured by the headache impact test (HIT).

29 June 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10194-010-0200-9

Attitudes and burden of disease among self-considered migraineurs--a nation-wide population-based survey in Sweden.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10194-010-0200-9

Patterns of specific antimigraine drug use--a study based on the records of 18 community pharmacies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10194-010-0200-9

Clinical features and pharmacological treatment of migraine patients referred to headache specialists in Canada.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10194-010-0200-9

Population-based door-to-door survey of migraine in Japan: the Daisen study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10194-010-0200-9

Migrainous disorder and its relation to migraine without aura and migraine with aura. A genetic epidemiological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10194-010-0200-9

Societal perspective on the burden of migraine in The Netherlands

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10194-010-0200-9

Assessment of migraineurs referred to a specialist headache clinic in Singapore: diagnosis, treatment strategies, outcomes, knowledge of migraine treatments and satisfaction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10194-010-0200-9

Migraine and probable migraine--results of FRAMIG 3, a French nationwide survey carried out according to the 2004 IHS classification.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10194-010-0200-9

Migraine treatment strategies: the global Migraine And Zolmitriptan Evaluation (MAZE) survey--phase IV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10194-010-0200-9

Probable migraine in the United States: results of the American Migraine Prevalence and Prevention (AMPP) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10194-010-0200-9

Migraine prophylactic medication usage patterns in The Netherlands

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10194-010-0200-9

A multinational investigation of the impact of subcutaneous sumatriptan. II: Health-related quality of life.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3451912

Impact of migraine and tension-type headache on life-style, consulting behaviour, and medication use: a Canadian population survey

22 September 2018

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3451912

22 September 2018

https://api.crossref.org/works/10.1007%2FS10194-010-0200-9

One-Year Prevalence of Migraine in Austria: A Nation-Wide Survey

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3451912

Patterns of health care utilization for migraine in England and in the United States

21 October 2018

1 reference

12 December 2020

Medical consultation for migraine: results from the American Migraine Study

1 reference

12 December 2020

FRAMIG 2000: medical and therapeutic management of migraine in France

1 reference

12 December 2020

Prevalence, pattern and predictors of use of complementary and alternative medicine (CAM) in migraine patients attending a headache clinic in Italy

1 reference

12 December 2020

Headache patients in primary care and a tertiary care unit in Zürich, Switzerland

1 reference

12 December 2020

Patterns of diagnosis and acute and preventive treatment for migraine in the United States: results from the American Migraine Prevalence and Prevention study

1 reference

12 December 2020

10.1007/S10194-010-0200-9

Identifiers

DOI

1 reference

13 August 2017

1 reference

13 August 2017

PubMed publication ID

20213485

1 reference